[2]
It is Novopharm's position that the Orders are too narrow in their scope in that they fail to protect all of the documents which Novopharm has been ordered to produce pursuant to s. 6(7) of the
Patented Medicines (Notice of Compliance) Regulations
("
Regulations
").